Clinical trial
Neuromodulation Through Brain Stimulation-assisted Cognitive Training in Patients With Post-COVID-19 Cognitive Impairment
NCT04944147 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuromodulation Through Brain Stimulation-assisted Cognitive Training in Patients With Post-COVID-19 Cognitive Impairment
- Lead sponsor
- University Medicine Greifswald
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 5, 2022
- Completion date
- October 8, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, post-covid-19